Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
29.01
+2.16 (8.04%)
At close: Dec 20, 2024, 4:00 PM
29.03
+0.02 (0.07%)
After-hours: Dec 20, 2024, 5:35 PM EST
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.31 billion as of December 20, 2024. Its market cap has increased by 1.24% in one year.
Market Cap
2.31B
Enterprise Value
1.55B
1-Year Change
1.24%
Ranking
Category
Stock Price
$29.01
Market Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.31B, an increase of 604.01%. That is a compound annual growth rate of 49.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 2.31B | 6.93% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | 4.61B | 1,305.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tandem Diabetes Care | 2.19B |
| Mesoblast | 2.18B |
| CONMED | 2.16B |
| Ligand Pharmaceuticals | 2.15B |
| IDEAYA Biosciences | 2.14B |
| NeoGenomics | 2.11B |
| LeMaitre Vascular | 2.07B |
| GeneDx Holdings | 2.07B |